Bufocort® HFA Inhaler

Budesonide + Formoterol Fumarate Dihydrate
Muscarinic Antagonist+ Beta-2 Agonist (Antiasthma)

Indication:
• Asthma in patients 12 years of age and older
• Maintenance treatment of chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema

Dosage & Administration:
• Asthma: 12 years and older: 2 puffs twice daily
• COPD: Adult: 2 puffs twice daily
Route of Administration: Inhalation (Oral)

Preparation:
Bufocort® 160 HFA MDI: Each Inhaler delivers 120 puffs.



  • Products By Trade Name

  • Products By Generic

  • Products By Therapeutic Class

  • Herbal & Nutraceuticals

  • AgroVet & Pesticides